- Home
- EBMT vs OBIO Comparison
EBMT vs OBIO Comparison
Compare EBMT & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- OBIO
- Stock Information
- Founded
- EBMT 1922
- OBIO 2017
- Country
- EBMT United States
- OBIO United States
- Employees
- EBMT N/A
- OBIO N/A
- Industry
- EBMT Major Banks
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- EBMT Finance
- OBIO Health Care
- Exchange
- EBMT Nasdaq
- OBIO Nasdaq
- Market Cap
- EBMT 125.3M
- OBIO 118.8M
- IPO Year
- EBMT N/A
- OBIO N/A
- Fundamental
- Price
- EBMT $16.55
- OBIO $2.57
- Analyst Decision
- EBMT
- OBIO Strong Buy
- Analyst Count
- EBMT 0
- OBIO 4
- Target Price
- EBMT N/A
- OBIO $14.00
- AVG Volume (30 Days)
- EBMT 33.1K
- OBIO 393.4K
- Earning Date
- EBMT 07-29-2025
- OBIO 08-12-2025
- Dividend Yield
- EBMT 3.47%
- OBIO N/A
- EPS Growth
- EBMT 49.06
- OBIO N/A
- EPS
- EBMT 1.61
- OBIO N/A
- Revenue
- EBMT $84,696,000.00
- OBIO $2,944,000.00
- Revenue This Year
- EBMT N/A
- OBIO $20.47
- Revenue Next Year
- EBMT $5.11
- OBIO $11.45
- P/E Ratio
- EBMT $10.38
- OBIO N/A
- Revenue Growth
- EBMT 5.13
- OBIO 41.61
- 52 Week Low
- EBMT $13.09
- OBIO $2.37
- 52 Week High
- EBMT $18.49
- OBIO $7.04
- Technical
- Relative Strength Index (RSI)
- EBMT 50.73
- OBIO 40.46
- Support Level
- EBMT $15.50
- OBIO $2.50
- Resistance Level
- EBMT $17.08
- OBIO $2.75
- Average True Range (ATR)
- EBMT 0.37
- OBIO 0.18
- MACD
- EBMT 0.09
- OBIO -0.03
- Stochastic Oscillator
- EBMT 66.46
- OBIO 11.47
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.